The University of Sheffield Principal Investigator: Professor Peter W Andrews Co-Principal Investigator: Dr Ivana Barbaric · Researcher: Mr Jason Halliwell , PhD student Areas of expertise - Culture a

University Medical Center Utrecht Principal Investigator: Prof. Joost Sluijter Researcher: Eveleyne Deemkes, PhD Student Areas of expertise - Empowering cardiac cell therapy - Human in vitro models fo

Conference Office If you have any queries you can reach Hannah Arpke under Info.TechnoBeat@mh-hannover.de

Scientific Publications 2016 Kempf H, Olmer R, Haase A, Franke A, Bolesani E, Schwanke K, Robles-Diaz D, Coffee M, Göhring G, Dräger G, Pötz O, Joos TO, Martinez-Hackert E, Haverich A, Buettner FF, Ma

Was ist die beste Lizenz für Open-Access Veröffentlichungen und warum ist es CC-BY? Das DEAL-Konsortium startet eine Informationskampagne, um wissenschaftliche Autor*innen in Deutschland für die Bedeu

Concept and Aims Cardiovascular diseases, including myocardial infarction (MI), are the leading cause of pre-mature death worldwide, constituting a major socio-economic burden on the European and glob

Activities The research work in TECHNOBEAT is divided into 9 work packages (WPs) with a specific partner dedicated to lead respective WPs which reflects that partners’ area of expertise. Within TECHNO

Speakers Peter Andrews, University of Sheffield, UK Johann Bauersachs, Hannover Medical School, GER Nissim Benvenisty, The Hebrew University Jerusalem, ISR Paul Burridge, Feinberg School of Medicine,

Consortium structure and expertise The TECHNOBEAT consortium is particularly well-equipped to significantly impact on the enormous challenges ahead in hiPSC-based cell therapies, as it gathers a uniqu

Organising Committee Robert Zweigerdt Ulrich Martin Hannover Medical School, Germany Christine Mummery Leiden University Medical Center, NL Peter Andrews University of Sheffield, UK Joost Sluijter Uni